Lexotanil (Bromazepam) 3mg
Generic Name: Bromazepam
Bromazepam, sold under many brand names, is a benzodiazepine. It is mainly an anti-anxiety agent with similar side effects to diazepam. In addition to being used to treat anxiety or panic states, bromazepam may be used as a premedicant prior to minor surgery.
$169.00 – $239.00
Shipped from EU.
Lexotanil (Bromazepam) 3mg pills/tablets:
Lexotanil (Bromazepam) Bromazepam is a benzodiazepine derivative drug, patented by Roche in 1963 and developed clinically in the 1970s. It has mainly an anti-anxiety agent with similar side effects to diazepam.
You can buy Lexotanil (Bromazepam) 3mg tablets online without prescription (No RX).
Lexotanil is an intermediate-acting tranquilizer, prescribed for the treatment of moderate to severe anxiety and panic disorders and for the short-term treatment of insomnia. Unlike the benzodiazepine alprazolam, it does not possess any antidepressant qualities.
In low doses, it diminishes anxiety and tension. In higher doses, the sedative and muscle-relaxant properties appear.
Average Dosing for Outpatient Therapy: 1.5-3 mg up to 3 times daily.
Severe Cases, Especially in Hospital: 6-12 mg 2 or 3 times daily.
These amounts are general recommendations, and the dosage should be individually determined. Treatment of outpatients should begin with low doses, gradually increasing to the optimum level. The duration of treatment should be as short as possible. The patient should be re-assessed regularly and the need for continued treatment should be evaluated, especially in case the patient is symptom-free. The overall treatment generally should not be >8-12 weeks, including a tapering-off process. In certain cases, extension beyond the maximum treatment period may be necessary, if so, it should not take place without re-evaluation of the patient’s status with special expertise.
Special Dosage Instructions: Lexotanil is usually not indicated in children, but if the physician feels Lexotanil treatment is appropriate, then the dose should be adjusted to their low body weight (about 0.1–0.3 mg/kg body weight).
Elderly patients and those with impaired hepatic function require lower doses because of individual variations in sensitivity and pharmacokinetics.
Lexotanil undergoes hepatic microsomal oxidation via the cytochrome P450 liver enzymes.
Therefore, caution should be taken in patients taking medicines that inhibit the P450 liver enzymes (e.g. azole antifungals, macrolide antibiotics, HIV protease inhibitors, calcium channel blocking agents).
Lexotanil undergoes oxidative metabolism and, consequently, may interact with disulfiram or cimetidine resulting in increased plasma levels of Lexotanil. Patients should be observed closely for evidence of enhanced benzodiazepine response during concomitant treatment with either disulfiram or cimetidine; some patients may require a reduction in benzodiazepine dosage.
The benzodiazepines, including Lexotanil, produce additive CNS depressant effects when coadministered with other medications which themselves produce CNS depression e.g. barbiturates, alcohol, sedatives, antidepressants, hypnotics, anxiolytics, phenothiazines, and other antipsychotics,
skeletal muscle relaxants, antihistamines, narcotic analgesics, and anesthetics.
Alcohol should be avoided in patients receiving Lexotanil.
In the case of narcotic analgesics enhancement of euphoria may also occur, leading to an increase in psychic drug dependence.
The anticholinergic effects of atropine and similar medicines, antihistamines, and antidepressants may be potentiated.
Interactions have been reported between some benzodiazepines and anticonvulsants, with changes in the serum concentration of the benzodiazepine or anticonvulsant. It is recommended that patients be observed for altered responses when benzodiazepines and anticonvulsants are prescribed together and that serum level monitoring of the anticonvulsant be performed more frequently.
Interference with Clinical, Laboratory, or Other Tests:
Minor EEG changes, usually low voltage fast activity, of no known clinical significance, has been
reported with benzodiazepine administration.
Lexotanil side effects
Post-Marketing: Lexotanil is well tolerated in therapeutic doses. The following adverse reactions may occur: Psychiatric Disorders: Confusional state, emotional disorder. These phenomena occur predominantly at the start of therapy and usually disappear with repeated administration. Libido disorders have been reported occasionally.
Depression: Preexisting depression may be unmasked during benzodiazepine use.
Paradoxical Reactions eg, restlessness, agitation, irritability, aggression, delusion, anger, nightmares, hallucinations, psychosis, inappropriate behaviour and other adverse behavioral effects are known to occur with benzodiazepines or benzodiazepine-like agents. Should this occur, the use of Lexotanil should be discontinued. They are more likely to occur in children and elderly patients than in other patients.
Dependence: Chronic use (even at therapeutic doses) may lead to the development of physical and psychic drug dependence: Discontinuation of therapy may result in withdrawal or rebound phenomena.
Abuse of benzodiazepines has been reported.
Nervous System Disorder: Drowsiness, headache, dizziness, decreased alertness, ataxia. These phenomena occur predominantly at the start of therapy and usually disappear with repeated administration.
Anterograde amnesia may occur using therapeutic dosages, the risk increasing at higher dosages. Amnestic effects may be associated with inappropriate behavior.
Eye Disorders: Diplopia, this phenomenon occurs predominantly at the start of therapy and usually disappears with repeated administration.
Gastrointestinal Disorders: Gastrointestinal disorders have been reported occasionally.
Skin and Subcutaneous Tissue Disorders: Skin reactions have been reported occasionally.
Musculoskeletal and Connective Tissue Disorders: Muscle weakness, this phenomenon occurs predominantly at the start of therapy and usually disappears with repeated administration.
General Disorders and Administration Site Conditions: Fatigue, this phenomenon occurs predominantly at the start of therapy and usually disappears with repeated administration.
Injury, Poisoning, and Procedural Complications: There have been reports of falls and fractures in benzodiazepine users. The risk is increased in those taking concomitant sedatives (including alcoholic beverages) and in the elderly.
Respiratory Disorders: Respiratory depression.
Cardiac Disorders: Cardiac failure including cardiac arrest.
Is Bromazepam a sleeping pill?
This medication belongs to the benzodiazepine family. Typically, it is used to reduce anxiety. It may also be used to help induce sleep.
Is Bromazepam stronger than diazepam?
Each drug was given for 3 weeks in a dose of 5 mg t.d.s. Bromazepam proved to be statistically significantly superior to diazepam when evaluated through patients’ preferences.
How much Bromazepam should I take to sleep?
Bromazepam was administered in a single dose of 1.5 mg one-half hour before bedtime to study its short-term action and the effect of its discontinuation on the sleep of 6 children suffering from night terrors.
How long does it take for Bromazepam to kick in?
Its effects can be felt within two to three hours of ingestion and could last for anywhere between eight and twelve hours, depending on your physiology. Because bromazepam is addictive, it’s recommended never to be used for longer than six weeks.
Is Bromazepam addictive?
It is especially addictive due to how its active component modifies the actual chemical structure of your brain after use for an extended period. Bromazepam typically comes in tablet form and like many other benzodiazepines; it has a dark side that can easily lead to substance abuse for those who take it.
What is Bromazepam 3 mg used for?
It is mainly an anti-anxiety agent with similar side effects to diazepam (Valium). In addition to being used to treat anxiety or panic states, bromazepam may be used as a premedicant prior to minor surgery. Bromazepam typically comes in doses of 3 mg and 6 mg tablets.
What is the half-life of Bromazepam?
Bromazepam has the pharmacokinetic characteristics of benzodiazepines with half-life values between 20 and 30 hours.